Is a 25 mg intravenous push of diltiazem appropriate for a 72‑year‑old female weighing 76 kg?

Diltiazem 25 mg IV Push Dosing Assessment

A 25 mg IV push of diltiazem is appropriate and within guideline-recommended dosing for this 72-year-old, 76 kg female patient. This dose falls within the FDA-approved range and matches the guideline-recommended second bolus dose for rate control in atrial fibrillation or supraventricular tachycardia.

Dosing Calculation and Guideline Alignment

For this patient's weight (76 kg), the guideline-recommended dosing is:

• Initial bolus: 0.25 mg/kg = 19 mg (typically rounded to 20 mg) 1, 2, 3
• Second bolus (if needed after 15 minutes): 0.35 mg/kg = 26.6 mg (typically rounded to 25 mg) 1, 2, 3

The 25 mg dose represents the appropriate second-line bolus dose per ACC/AHA/HRS guidelines and FDA labeling 1, 2, 3. The FDA label explicitly states "25 mg is a reasonable dose for the average patient" for the second bolus 3.

Administration Protocol

The diltiazem should be administered:

• Over 2 minutes (not as a rapid push) 1, 2, 3
• Only if the initial 20 mg dose was inadequate after 15 minutes 2, 3
• Followed by continuous infusion (5-15 mg/h) if sustained rate control is needed 1, 3

Critical Safety Considerations

Before administering, exclude these absolute contraindications:

• AV block greater than first degree or sick sinus syndrome (without pacemaker)
• Decompensated systolic heart failure or severe LV dysfunction
• Hypotension (systolic BP <90-100 mmHg)
• WPW syndrome with atrial fibrillation/flutter
• Cardiogenic shock 1, 2

Monitor closely for adverse effects:

• Hypotension (most common, occurring in 18-42% depending on dose) 4, 5
• Bradycardia
• Worsening heart failure in patients with pre-existing ventricular dysfunction 1, 2

Evidence-Based Efficacy

Research demonstrates that weight-based diltiazem dosing achieves:

• 95-97% therapeutic response rate in appropriate patients 6
• Heart rate reduction within 5 minutes of administration 7
• Superior efficacy compared to digoxin for acute rate control 7

However, studies show that lower doses (<0.2 mg/kg) may be equally effective with significantly less hypotension (18% vs 35% hypotension rate) 4. For this 76 kg patient, a lower initial dose of 15 mg might be considered if hypotension risk is elevated, though this represents off-label dosing.

Clinical Decision Algorithm

1. Verify indication: Atrial fibrillation/flutter with RVR >120-150 bpm, or other SVT
2. Confirm no contraindications (see above list)
3. Check baseline vitals: Ensure systolic BP >100 mmHg, no severe bradycardia
4. If this is the FIRST dose: Consider starting with 20 mg (0.25 mg/kg) instead
5. If this is the SECOND dose (after inadequate response to initial 20 mg): 25 mg is appropriate
6. Administer over 2 minutes with continuous cardiac monitoring
7. Prepare for infusion if bolus effective but sustained control needed

Common Pitfalls to Avoid

• Overdosing: Many practitioners exceed recommended doses by >10%, increasing hypotension risk 5, 8
• Too rapid administration: Must give over 2 minutes, not as rapid push 1, 2, 3
• Using in WPW with AF: Can precipitate ventricular fibrillation 2
• Inadequate monitoring: Hypotension can occur rapidly after administration 4
• Off-label underdosing: While lower doses may reduce hypotension, they often require additional rate control agents 8

The 25 mg dose is guideline-concordant for this patient's weight, assuming this represents the second bolus dose and all contraindications have been excluded 1, 2, 3.